Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma

被引:38
作者
Kim, Bong-Wan
Kim, Young-Bae
Wang, Hee-Jung
Kim, Myung-Wook
机构
[1] Ajou Univ, Sch Med, Dept Surg, Suwon 442749, South Korea
[2] Ajou Univ, Sch Med, Dept Pathol, Suwon 442749, South Korea
关键词
hepatocellular carcinoma; hepatectomy; early recurrence; risk factors;
D O I
10.3748/wjg.v12.i1.99
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the clinicopathological risk factors for immediate post-operative fatal recurrence of hepatocellular carcinoma (HCC), which may have practical implication and contribute to establishing high risk patients for pre- or post-operative preventive measures against HCC recurrence. METHODS: From June 1994 to May 2004, 269 patients who received curative resection for HCC were reviewed. Of these patients, those who demonstrated diffuse intrahepatic or multiple systemic recurrent lesions within 6 mo after surgery were investigated (fatal recurrence group). The remaining patients were designated as the control group, and the two groups were compared for clinicopathologic risk factors. RESULTS: Among the 269 patients reviewed, 30 patients were enrolled in the fatal recurrence group. Among the latter, 20 patients showed diffuse intrahepatic recurrence type and 10 showed multiple systemic recurrence type. Multivariate analysis between the fatal recurrence group and control group showed that preoperative serum alpha-fetoprotein (AFP) level was greater than 1 000 mu g/L (P=0.02; odds ratio=2.98), tumor size greater than 6.5 cm (P=0.03; OR=2.98), and presence of microvascular invasion (P=0.01; OR=4.89) were the risk factors in the fatal recurrence group. The 48.1% of the patients who had all the three risk factors and the 22% of those who had two risk factors experienced fatal recurrence within 6 mo after surgery. CONCLUSION: Three distinct risk factors for immediate post-operative fatal recurrence of HCC after curative resection are pre-operative serum AFP level > 1000 mu g/L, tumor size > 6.5 cm, and microvascular invasion. The high risk patients with two or more risk factors should be the candidates for various adjuvant clinical trials. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 33 条
[1]   Liver transplantation for hepatocellular carcinoma [J].
Bismuth, H ;
Majno, PE ;
Adam, R .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322
[2]   Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results [J].
Buscarini, L ;
Buscarini, E ;
Di Stasi, M ;
Vallisa, D ;
Quaretti, P ;
Rocca, A .
EUROPEAN RADIOLOGY, 2001, 11 (06) :914-921
[3]  
CHEN MF, 1994, ARCH SURG-CHICAGO, V129, P738
[4]   Liver resection for hepatocellular carcinoma on cirrhosis - Univariate and multivariate analysis of risk factors for intrahepatic recurrence [J].
Ercolani, G ;
Grazi, GL ;
Ravaioli, M ;
Del Gaudio, M ;
Gardini, A ;
Cescon, M ;
Varotti, G ;
Cetta, F ;
Cavallari, A .
ANNALS OF SURGERY, 2003, 237 (04) :536-543
[5]   An analysis of 412 cases of hepatocellular carcinoma at a western center [J].
Fong, YM ;
Sun, RL ;
Jarnagin, W ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 229 (06) :790-799
[6]  
Hanazaki K, 2001, AM J GASTROENTEROL, V96, P1243, DOI 10.1111/j.1572-0241.2001.03634.x
[7]  
Ikeda Y, 1995, HEPATO-GASTROENTEROL, V42, P469
[8]   Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy [J].
Imamura, H ;
Matsuyama, Y ;
Tanaka, E ;
Ohkubo, T ;
Hasegawa, K ;
Miyagawa, S ;
Sugawara, Y ;
Minagawa, M ;
Takayama, T ;
Kawasaki, S ;
Makuuchi, M .
JOURNAL OF HEPATOLOGY, 2003, 38 (02) :200-207
[9]   Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection? [J].
Jeng, KS ;
Sheen, IS ;
Tsai, YC .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08) :1503-1509
[10]  
*KOR LIV CANC STUD, 2004, GEN RUL STUD PRIM LI, P41